Patterns of Prophylactic Anticoagulation Among Patients Hospitalized for COVID‐19: An Analysis of the American Heart Association COVID‐19 Cardiovascular Disease Registry
Background Limited knowledge exists about prophylactic anticoagulation patterns in patients hospitalized for COVID‐19. Methods and Results We conducted a retrospective cohort study using American Heart Association COVID‐19 Cardiovascular Disease Registry data from May 2020 to March 2022. We included...
Saved in:
| Main Authors: | Mathew S. Lopes, Hsin‐Fang Li, Reed J. D. Sorensen, Sandeep Das, Steven M. Bradley, James A. de Lemos, Gregory A. Roth, Tracy Wang, Erin A. Bohula, Ty J. Gluckman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.034186 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LEFLUNOMIDE USE IN THE PROPHYLACTIC TREATMENT OF GOUT
by: Gezmiş Kimyon
Published: (2025-03-01) -
Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic
by: A. S. Polyakov, et al.
Published: (2021-09-01) -
Variability in the Homeopathic Treatment of COVID-19 Patients: Findings of the Clificol International Clinical Case Registry
by: Yvonne Fok, et al.
Published: (2025-01-01) -
Challenges and Opportunities in Establishing a COVID-19 Patient Registry in a Regional Setting in the Philippines
by: Gerard G. Dumancas, et al.
Published: (2024-11-01) -
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial
by: Toby J. L. Humphrey, et al.
Published: (2025-02-01)